🩺 CPT Code 52005: Documentation & Billing Guide
Cystourethroscopy with ureteral catheterization, irrigation, instillation, ureteropyelography
Last Updated: February 2026
Status: 2025 Medicare Fee Schedule Compliant
Specialty Tags: urology endoscopy diagnostic ureteralpylography CPT medical_coding urology
Quick Reference Table
| Element | Details |
|---|---|
| CPT Code | 52005 |
| Code Type | Diagnostic Procedure - Urology/Endoscopy |
| Procedure Type | cystourethroscopy with ureteral catheterization, ±irrigation, instillation, ureteropyelography (imaging exclusive) |
| Global Period | 000 (Minor procedure, no global period) |
| Work RVU (2025) | 0.52 |
| PE RVU (2025, Non-Facility) | 0.48 |
| PE RVU (2025, Facility) | 0.16 |
| Malpractice RVU (2025) | 0.04 |
| Total RVU (2025, Non-Facility) | 1.04 |
| Total RVU (2025, Facility) | 0.72 |
| Medicare Payment (Non-Facility) | ~$33.67 |
| Medicare Payment (Facility) | ~$23.31 |
| 2025 Conversion Factor | $32.35 |
| Estimated Commercial Insurance | $350 - 1,000+ |
| Medicaid Range (State-Dependent) | $40 - 200 |
| Procedure Time | 20-45 minutes |
| Place of Service | Office (11), Outpatient Hospital (22), ASC (24) |
| Typical Specialty | Urology, Gynecology, Internal Medicine |
📋SHORT DEFINITION
CPT 52005 describes cystourethroscopy (endoscopic visualization of bladder and urethra) with passage of a catheter into the ureter for diagnostic purposes, allowing evaluation of the ureter and collecting system, with optional irrigation, instillation of medications, and/or ureteropyelography (retrograde study of the upper urinary tract). The radiologic imaging costs are NOT included in this code (“exclusive of radiologic service”).
LONG DEFINITION
Overview
CPT 52005 is a diagnostic urologic procedure combining cystoscopy (visualization of bladder and urethra) with ureteral catheterization - passage of a small catheter into the ureter to evaluate the ureteral anatomy, detect obstruction, and visualize the upper urinary tract.
Key points:
- Endoscopic visualization of bladder, urethra, and ureteral orifice
- Passage of ureteral catheter through ureter into collecting system
- Allows diagnostic evaluation, sample collection, medication instillation
- Does NOT include radiologic imaging costs (separate radiology code required if retrograde pyelography performed)
- Can include irrigation and instillation of contrast or medications
Clinical Indications
1. Evaluation of Upper Urinary Tract Obstruction
- Suspected ureteral obstruction (stone, stricture, mass, blood clot)
- Need to determine if obstruction is complete or partial
- Assess ureteral anatomy proximal to obstruction
- Ureteral catheter helps delineate anatomy on retrograde pyelography
2. Ureteral Stone Management
- Initial diagnostic assessment of stone (location, size, radiopacity)
- Retrograde pyelography to visualize stone and surrounding ureter
- Therapeutic stent placement (stent counts as separate procedure if coded separately)
- Preparation for ureteroscopic removal
3. hematuria Workup - Upper Urinary Tract
- Gross or microscopic hematuria of unclear etiology
- Cystoscopy to evaluate bladder (rule out bladder source)
- Ureteral catheterization to evaluate ureter/collecting system
- Retrograde pyelography for detailed imaging of upper tract
4. Suspected Ureteral Stricture or Injury
- Post-surgical ureteral injury
- Post-radiation changes
- Retroperitoneal fibrosis compressing ureter
- Ureteral catheterization assesses degree of stricture
5. Collection of Upper Urinary Tract Specimens
- Urine culture from ureter/renal pelvis (can be sterile collection)
- Cytology for malignancy evaluation
- Catheter-directed specimen collection
6. Instillation of Medication into Upper Urinary Tract
- Chemotherapy instillation for bladder tumors with upper tract involvement
- Uric acid dissolution agents for uric acid stones
- Antibiotic or contrast instillation
7. Diagnosis of Upper Tract Pathology
- Urothelial cancer evaluation
- Transitional cell carcinoma suspected
- Retrograde pyelography for tumor staging
Procedure Technique
Patient Preparation:
- NPO status per anesthesia requirements (usually 2-4 hours)
- Urinalysis and urine culture before procedure (document baseline)
- Baseline renal function (creatinine, BUN) if dye planned
- Medications: Hold aspirin, anticoagulants per protocol
- Anesthesia: Usually local anesthesia with sedation or general anesthesia
- Patient positioned supine or lithotomy
- Sterile draping of genitalia
Equipment:
- Cystoscope (flexible or rigid)
- Light source and camera
- Ureteral catheter (typically 6-7 Fr, various materials: polyurethane, silicone)
- Guidewire (for difficult ureteral catheterization)
- Irrigation fluid (normal saline or other)
- Contrast medium (if retrograde pyelography planned)
- Specimen collection containers if cultures/cytology planned
Operative Steps:
-
cystoscopy - Initial Bladder Survey:
- Cystoscope inserted through urethra into bladder
- Bladder emptied; filled with irrigation fluid for visualization
- Bladder mucosa inspected: Color, tumors, stones, blood, discharge
- Ureteral orifices identified (normally located posterolaterally at trigone)
- Assess ureteral orifices: Shape (golf hole vs stadium), peristalsis, patency
-
Ureteral Orifice Identification - CRITICAL:
- Locate ureteral orifice(s) - typically two, one on each side of trigone
- Right ureteral orifice: Usually more medial and lower
- Left ureteral orifice: Usually more lateral and higher
- Assess opening: Normal “golf hole” appearance vs dilated “stadium” appearance (suggests obstruction)
- Check for ureteral peristalsis (rhythmic contractions indicating normal ureteral activity)
-
Ureteral Catheterization Technique:
- Pass ureteral catheter under direct visualization through cystoscope
- Catheter advanced gently into ureteral orifice
- Resistance encountered? → Stricture or obstruction
- Catheter advanced into ureter, typically to mid-ureter or renal pelvis (distance ~20-30 cm)
- Rule of thumb: Catheter advanced until resistance met or visualized in renal pelvis on imaging
- If difficult passage → May need guidewire to facilitate catheterization
-
Diagnostic Activities (Depending on Indication):
A. Urine Specimen Collection:
- Urine aspirated through catheter for culture (sterile collection)
- Urine sent for culture and sensitivity
- Cytology if malignancy suspected
B. Irrigation and Observation:
- Bladder irrigated with saline; observe for appearance of urine from ureter
- Urine character noted: Clear, cloudy, bloody?
- Assess ureteral peristalsis during observation
C. Retrograde pyelography (if indicated - requires separate radiology code):
- Contrast instilled through catheter into ureter and collecting system
- Fluoroscopic imaging of upper urinary tract
- Identifies stones, strictures, tumors, other obstructions
- Radiologic imaging code (e.g., 74420) billed separately
D. Medication Instillation:
- If therapeutic: Contrast, medications, or agents instilled through catheter
- Left in contact with upper urinary tract for therapeutic effect
- Catheter withdrawn
-
Catheter Withdrawal:
- Catheter slowly withdrawn under visualization
- Observe ureteral orifice: Does it bleed or show trauma?
- Minor oozing expected; significant bleeding → possible perforation
-
Completion:
- Final bladder survey to rule out complications
- Bladder drained
- Cystoscope withdrawn
- Patient to recovery
Post-Operative:
- Dysuria expected for 24-48 hours
- Encourage hydration (flush the urinary system)
- Antibiotics if culture positive or prophylaxis given
- Monitor for signs of infection, ureteral injury
- Follow-up imaging if retrograde pyelography performed
Typical Duration: 20-45 minutes (depending on catheterization difficulty, need for imaging, specimen collection)
KEY DISTINCTIONS - Similar CPT Codes
| Code | Description | Catheterization | Biopsy | RVU (Work) |
|---|---|---|---|---|
| 52005 | Cystourethroscopy with ureteral catheterization | Yes, catheter passage | No | 0.52 |
| 52000 | Cystourethroscopy (diagnostic, separate procedure) | No catheter | No | 0.36 |
| 52007 | cystourethroscopy with ureteral catheterization + brush biopsy | Yes, catheter + biopsy | Yes (brush) | 0.81 |
| 52204 | Cystourethroscopy with biopsy (bladder biopsy, no ureteral catheter) | No | Yes (bladder) | 0.58 |
Critical Distinctions:
- 52005 vs 52000: 52005 includes ureteral catheterization; 52000 is diagnostic cystoscopy only
- 52005 vs 52007: 52005 is catheterization/irrigation only; 52007 includes brush biopsy of ureter/renal pelvis (higher RVU: 0.81 vs 0.52)
- 52005 cannot be billed with TURBT codes (52224, 52234, 52235, 52240) - retrograde pyelogram is bundled into TURBT per CCI edits
- 52005 vs 52204: 52005 is upper tract diagnostic; 52204 is bladder biopsy (different anatomic site and indication)
RVU BREAKDOWN - 2025
Work RVU Components
| Component | Value | Represents |
|---|---|---|
| Work RVU | 0.52 | Physician skill, diagnostic interpretation, decision-making |
| PE RVU (Non-Facility) | 0.48 | Cystoscope, catheters, supplies, support staff |
| PE RVU (Facility) | 0.16 | Lower in facility (hospital/ASC provides equipment) |
| Malpractice RVU | 0.04 | Malpractice insurance (minor procedure, low risk) |
| TOTAL (Non-Facility) | 1.04 | Sum of all components |
| TOTAL (Facility) | 0.72 | Lower due to reduced PE RVU |
Conversion to Dollar Amount (2025 Medicare)
Formula: RVU × Conversion Factor (CF) × Geographic Practice Cost Index (GPCI) = Payment
2025 CF: $32.35
Non-Facility Calculation (GPCI = 1.0):
- Work: 0.52 × 16.82**
- PE: 0.48 × 15.53**
- MP: 0.04 × 1.29**
- Total = $33.67
Facility Calculation (GPCI = 1.0):
- Work: 0.52 × 16.82**
- PE: 0.16 × 5.18**
- MP: 0.04 × 1.29**
- Total = $23.31
Real-World Ranges (2025)
| Setting | Range | Notes |
|---|---|---|
| Non-Facility (Office) | $30 - 40 | Varies by GPCI |
| Facility (Hospital/ASC) | $20 - 28 | Lower PE RVU |
| Commercial Insurance | $350 - 1,000+ | 10-30× Medicare; payer-dependent |
| Medicaid | $40 - 200 | State-dependent; highly variable |
| Self-Pay Cash | $200 - 400 | Office practices charge |
2024 vs 2025 Comparison
| Metric | 2024 | 2025 | Change |
|---|---|---|---|
| Work RVU | 0.52 | 0.52 | — |
| PE RVU (Non-Fac) | 0.48 | 0.48 | — |
| CF | $33.29 | $32.35 | -2.83% |
| National Average (Non-Fac) | ~$34.65 | ~$33.67 | -2.83% |
GLOBAL PERIOD - 000 (Minor Procedure)
Status: 000 - No Global Period (or minimal 0-day global)
What This Means:
- 52005 has no global period (000 code - minor procedure)
- No pre-operative or post-operative bundling
- All services billed independently
- Post-operative visits for unrelated conditions can be billed same day without restriction
Billing Implications:
- Can bill 52005 + office visit (99213-99215) same day - No modifier needed on either code
- Can bill 52005 + other procedures same day - Standard independent billing
- No post-operative global restrictions - Patient can be seen for other issues immediately after without bundling
- Repeat procedure (if needed within 90 days) - No global period restriction applies
DOCUMENTATION REQUIREMENTS - CRITICAL
Pre-Procedure Assessment
History - Must Document:
- Indication for procedure: Why is ureteral catheterization medically necessary TODAY?
- Hematuria workup?
- Suspected stone?
- Recurrent UTI evaluation?
- Possible obstruction?
- Upper tract surveillance (cancer, stricture)?
- Symptom history: dysuria? Flank pain? Hematuria (gross or micro)? When did symptoms start?
- Prior urologic history: Previous stones, strictures, obstructions, upper tract surgery?
- Renal function: Recent creatinine, BUN (baseline for contrast exposure if pyelography planned)
- Allergy history: Contrast allergy? Latex allergy?
- Anticoagulation: On aspirin, warfarin, antiplatelet agents? (May need adjustment)
Cystoscopy Pre-Procedure Exam:
- Voiding history: Normal stream? Hesitancy? nocturia? Urinary frequency?
- Gross hematuria vs microscopic: Which present?
- Abdominal exam: Flank tenderness? CVA (costovertebral angle) tenderness?
- Baseline vital signs: BP, HR (establish baseline)
Intra-Operative Documentation - CRITICAL
Cystoscopy Findings:
- Bladder mucosa: Color and appearance (normal pink vs erythematous/inflamed)
- Bladder capacity: Normal, contracted, distended?
- Bladder pathology: Blood, clots, tumors, stones, diverticula?
- Trigone: Normal anatomy?
- Ureteral orifices: Describe EACH orifice
- Right ureteral orifice:
- Appearance (normal “golf hole” vs dilated “stadium”)
- Peristalsis present? (rhythmic urine jets)
- Patency assessed?
- Left ureteral orifice:
- Appearance
- Peristalsis?
- Patency?
- Right ureteral orifice:
Ureteral Catheterization - CRITICAL:
- Catheter passed: Yes/No
- Ease of passage: Easy, difficult, required guidewire?
- Resistance encountered: At orifice? Within ureter? Complete obstruction or partial?
- Catheter position: How far advanced? (Distance from ureter orifice, e.g., “10 cm,” “20 cm,” “into renal pelvis”)
- Laterality: Which ureter catheterized? (Right vs left - CRITICAL)
- Catheter type/size: Fr size, material (polyurethane, silicone, etc.)
Diagnostic Findings (if applicable):
- Ureteral urine specimen: Appearance (clear, cloudy, bloody)
- Sent for culture? Cytology?
- Irrigation findings: Character of urine obtained (irrigant return clear or colored?)
- Retrograde pyelography (if performed):
- Performed? Yes/No
- Findings: Stones? Strictures? Dilatation? Filling defects?
- Entire collecting system visualized?
- Contrast extravasation? (Sign of perforation)
- Medication instillation: What agent? How much? How long left in contact?
Complications (if any):
- Ureteral bleeding: None vs minor oozing vs significant bleeding
- Ureteral perforation: Suspected? Evidence (contrast extravasation)?
- False passage: Created during catheterization?
- Difficulty: Any anatomic challenges (stricture, tortuous ureter)?
- Other complications: Vasovagal reaction, blood pressure changes?
Catheter Withdrawal:
- Catheter removed: Yes/No (or left in place if therapeutic stent placed)
- Withdrawal findings: Any resistance? Trauma to orifice?
- Post-withdrawal ureteral appearance: Normal? Bleeding?
End-of-Procedure:
- Final bladder survey: Any new pathology noted?
- Bladder drained: Yes/No (document residual urine if any)
- Estimated blood loss: None to minimal
- Complications: None vs specific issues
- Specimens: Obtained and labeled appropriately
Post-Operative Documentation
Patient Condition:
- Alert and stable on recovery
- Voiding prior to discharge? (If same-day procedure)
- dysuria expected vs concerning findings?
Discharge Instructions:
- Hydration: Encourage oral fluids
- Activity: Rest × 24 hours, avoid strenuous activity
- Medications: Antibiotics (if indicated), pain management
- When to call: Fever, hematuria >48 hours, inability to void, severe pain
- Follow-up: When to follow up for results (culture, imaging interpretation)
COMMON MODIFIERS
| Modifier | Description | Usage |
|---|---|---|
| -RT/-LT | Right/Left Ureter | If unilateral ureteral catheterization; clarifies which side (RT = right, LT = left) |
| -50 | Bilateral Procedure | If bilateral ureteral catheterization same day (rare); verify payer policy |
| -59 | Distinct Procedural Service | If 52005 billed with unrelated procedure same day (rarely needed) |
| -25 | Sig., Separately Identifiable E/M | If comprehensive E/M performed separately from procedure; apply to E/M |
| -26 | Professional Component Only | If billing interpretation only (imaging performed elsewhere) |
| -TC | Technical Component Only | If billing imaging/supplies only (interpretation billed separately) |
| None | Standard Billing | Routine unilateral ureteral catheterization |
Important Notes:
- -59 (CCI Edit Issue): 52005 bundled into TURBT codes (52224, 52234, 52235, 52240) per CCI. Cannot bill 52005 with TURBT unless distinct reason documented; use -59 with different diagnosis codes.
- Bilateral: Rarely performed same day; document carefully why both ureters catheterized.
- -RT/-LT: Clarifies laterality in unilateral procedures; highly recommended to document which ureter treated.
MEDICARE RULES & POLICIES
1. No Global Period - Diagnostic Procedure
- 52005 is 000 code; no global period
- No pre-operative or post-operative bundling
- Independent billing applies
2. Bundling with TURBT Codes (CCI Edit)
- 52005 is bundled with TURBT codes per Medicare NCCI edits:
- Cannot bill 52005 + 52224 (minor bladder tumor removal)
- Cannot bill 52005 + 52234 (small bladder tumor)
- Cannot bill 52005 + 52235 (medium bladder tumor)
- Cannot bill 52005 + 52240 (large bladder tumor)
- Exception: If retrograde pyelogram is performed for reason OTHER than TURBT, can bill with -59 modifier if separate diagnosis codes justify it
- Example: TURBT for bladder tumor (ICD-10 C67.x) + retrograde for ureteral stone (ICD-10 N20.1)
- Use -59 on 52005 with different diagnosis code
3. Retrograde Pyelography Billing
- 52005 includes the catheter passage and diagnostic evaluation
- Retrograde pyelography imaging billed separately: Radiology code (typically 74420 or 74425)
- 52005 code notes: “exclusive of radiologic service” → Radiologist bills imaging separately
- Example coding:
- 52005 (Ureteral catheterization - surgical/procedural component)
- 74420 (Retrograde ureteropyelography - radiologic component)
4. Urine Specimen Collection
- Urine specimen collection through catheter is included in 52005
- Culture cost is separate (specimen processing billable by lab)
- Do not bill separately for specimen collection
5. Bilateral vs Unilateral
- If bilateral catheterization same day, document why both sides were necessary
- May bill as:
- 52005 × 2 (some payers)
- 52005 with -50 modifier (other payers)
- Two separate lines with -RT and -LT (verification needed)
- Check payer policy before billing bilateral
6. Component Separation (-26/-TC)
- Rarely applicable; usually billed globally
- If split between surgeon and radiologist, use modifiers:
- -26 on 52005 (physician interpretation, surgical component)
- -TC on 74420 (radiology technical component)
- Ensure no duplicate billing between providers
NATIONAL & LOCAL COVERAGE
National Coverage Determination (NCD)
Status: NO specific NCD for CPT 52005 from CMS
General Medicare Coverage Policy:
- Cystourethroscopy with ureteral catheterization is covered when medically necessary
- Typically covered for:
- Diagnostic evaluation of hematuria (upper tract etiology)
- Upper urinary tract obstruction evaluation
- Stone disease assessment
- Stricture evaluation
- Upper tract cancer surveillance
- Therapeutic intervention support (e.g., stent placement)
Local Coverage Determinations (LCDs) - MAC-Specific
LCDs vary by Medicare Administrative Contractor (MAC) jurisdiction
| Requirement | Details |
|---|---|
| Medical Necessity | Clear indication: Hematuria, obstruction, stone disease, stricture, cancer surveillance |
| Imaging Correlation | Often requires imaging (ultrasound, CT) suggesting upper tract pathology before proceeding |
| Diagnosis Code | ICD-10 code documenting indication (hematuria, stone, obstruction, etc.) |
| Bundling | Check MAC rules for bundling with TURBT or other procedures |
| Frequency | Usually covered once per clinical problem; repeat only if new indication arises |
Common ICD-10 Codes Associated with 52005:
- R31.9: Hematuria, unspecified
- [[N20.0]]-N20.9: Calculus of kidney and ureter (stone disease)
- N13.0-N13.9: Obstructive uropathy and related disorders
- N35.0-N35.9: Urethral stricture
- C64-C68: Malignant neoplasm of urinary organs (surveillance)
- N39.0: Urinary tract infection, site not specified
- R82: Cytologic evidence of malignancy (if suspicious for urothelial cancer)
2025 MEDICARE FEE SCHEDULE
Medicare 2025 Fee Schedule Summary
| Category | Value |
|---|---|
| Work RVU | 0.52 |
| PE RVU (Non-Facility) | 0.48 |
| PE RVU (Facility) | 0.16 |
| Malpractice RVU | 0.04 |
| Total RVU (Non-Facility) | 1.04 |
| Total RVU (Facility) | 0.72 |
| Conversion Factor (2025) | $32.35 |
| National Average (Non-Facility, GPCI 1.0) | $33.67 |
| Estimated Range (Non-Facility) | $30 - 40 |
| National Average (Facility, GPCI 1.0) | $23.31 |
| Estimated Range (Facility) | $20 - 28 |
Year-over-Year Comparison (2024 vs 2025)
| Metric | 2024 | 2025 | Change |
|---|---|---|---|
| Work RVU | 0.52 | 0.52 | — |
| PE RVU (Non-Fac) | 0.48 | 0.48 | — |
| CF | $33.29 | $32.35 | -2.83% |
| National Average | ~$34.65 | ~$33.67 | -2.83% |
Commercial Insurance & Medicaid (2025)
| Payer Type | Estimated Range | Notes |
|---|---|---|
| Commercial | $350 - 1,000+ | 10-30× Medicare; highly payer-dependent |
| Medicaid | $40 - 200 | State-dependent; often less than Medicare |
| Self-Pay | $200 - 400 | Office practices typically charge |
AUDIT RED FLAGS & COMPLIANCE TIPS
Red Flags for Auditors
❌ No clear indication for ureteral catheterization
- Why was upper urinary tract evaluation necessary?
❌ Bundled incorrectly with TURBT
- 52005 billed with TURBT code without -59 modifier and separate diagnosis code
❌ Retrograde pyelography billed as included in 52005
- Radiology component must be billed separately (74420 or 74425)
❌ Bilateral catheterization without justification
- Documentation doesn’t explain why both ureters needed catheterization
❌ Specimen collection billed separately
- Urine collection through catheter is included in 52005
❌ Diagnosis code doesn’t match indication
- Code claims hematuria workup but diagnosis code is unrelated
❌ No documentation of catheter passage
- Critical documentation missing on whether ureteral catheter actually passed into ureter
Compliance Best Practices
✅ Always document clear medical necessity
- “Evaluate for upper urinary tract source of gross hematuria”
✅ Specify which ureter(s) catheterized
- “Right ureteral catheterization; left ureter patent without obstruction”
✅ Document catheter passage technique
- “Ureteral catheter passed easily into right ureter, advanced 22 cm to renal pelvis”
✅ Describe findings in detail
- “Right ureteral urine specimen clear; left ureteral orifice golf-hole appearance with normal peristalsis”
✅ If TURBT performed, use -59 modifier appropriately
- “52005-59 (distinct indication: ureteral stone evaluation)” if separate from bladder tumor removal
✅ Bill retrograde pyelography separately
- “52005 (catheterization) + 74420 (retrograde pyelography)”
✅ Document post-procedure status
- “Ureteral catheter removed without complication; mild ureteral oozing noted, resolved”
✅ Include specimen handling documentation
- “Urine specimen sent for culture and urinalysis”
FAQ - COMMON QUESTIONS
Q: What’s the difference between 52005 and 52007?
A: 52005 is ureteral catheterization with irrigation/instillation only. 52007 includes brush biopsy of ureter/renal pelvis (adds sampling component). 52007 RVU is higher (0.81 vs 0.52).
Q: Can I bill 52005 with TURBT?
A: Generally NO (bundled per CCI edits). Exception: If retrograde pyelogram is for different clinical reason (e.g., stone vs bladder tumor), use -59 modifier on 52005 with separate diagnosis codes. Always verify with your MAC.
Q: Is retrograde pyelography imaging included in 52005?
A: No. 52005 includes catheter passage and diagnostic evaluation. Radiologic imaging (retrograde pyelography) is billed separately with radiology CPT code (74420 or 74425). Note on 52005: “exclusive of radiologic service.”
Q: Can I bill 52005 if catheterization is difficult and takes longer?
A: Yes; procedure billed same regardless of time. RVU accounts for complexity. If multiple attempts required, document difficulty but bill 52005 once.
Q: What’s included in 52005 vs what’s separate?
A: INCLUDED: Cystoscopy, ureteral catheterization, irrigation, instillation. SEPARATE: Retrograde pyelography (radiology code), specimen processing (lab code), stent placement (separate code if applicable).
Q: Can I bill 52005 for both ureters same day?
A: Rarely indicated clinically. If both ureters need catheterization, document clearly why. Bill as 52005 × 2 or 52005 with -50 (check payer). Most commonly only one ureter is catheterized.
Q: Do I need ICD-10 diagnosis code for 52005?
A: Yes, absolutely. Must justify medical necessity with diagnosis code (hematuria, stone, stricture, obstruction, cancer surveillance, etc.).
Q: Can I bill 52005 with office visit same day?
A: Yes. 52005 has no global period (000 code). Bill independently without modifier if separate and identifiable.
BILLING SCENARIOS & EXAMPLES
Scenario 1: Gross Hematuria Workup (Office)
Patient: 62-year-old male with gross hematuria × 2 weeks
Clinical Assessment:
- Hematuria not resolved after 5 days antibiotics (presumed UTI initially)
- CT KUB: No stone, normal kidneys/ureters
- CBC, metabolic panel normal
- Previous hematuria history: None
Indication for 52005: Rule out upper urinary tract source (stone, mass, stricture) before assuming bladder source
Procedure:
- Cystoscopy: Normal bladder mucosa, no tumors, no clots
- Right ureteral orifice: Normal “golf hole” appearance, peristalsis present
- Left ureteral orifice: Normal, peristalsis present
- Right ureteral catheterization: Passed easily, advanced 25 cm into renal pelvis
- Urine specimen from right ureter: Clear, sent for culture
- Left ureteral catheterization: Easy passage, specimen collected, clear
- No retrograde pyelography performed
- Catheters removed without complication
Coding:
- 52005-RT (right ureteral catheterization)
- 52005-LT (left ureteral catheterization) OR 52005 × 2 (verify payer)
- ICD-10: R31.9 (gross hematuria, unspecified)
- Medicare Payment: ~67 total if bilateral reimbursable)
Scenario 2: Ureteral Stone with Retrograde Pyelography (ASC)
Patient: 48-year-old female with flank pain and hematuria
Clinical Assessment:
- CT KUB: 8 mm stone at right ureteropelvic junction (UPJ)
- Non-obstructive but symptomatic
- Referred for retrograde pyelography to assess stone and upper tract anatomy before ureteroscopy
Procedure:
- Cystoscopy: Normal bladder
- Right ureteral catheterization: Catheter passed, advanced 20 cm; resistance at UPJ (stone location)
- Right ureteral urine specimen: Clear, sent for culture
- Retrograde pyelography performed: Stone noted at UPJ with mild proximal hydroureteronephrosis
- Catheter withdrawn without complication
Coding:
- 52005-RT (ureteral catheterization, right ureter)
- 74420-RT (retrograde ureteropyelography, right side) - Billed by radiology
- ICD-10: N20.1 (calculus of ureter); R31.9 (hematuria)
- Medicare Payment for 52005: ~23.31)
- Separate radiology billing for 74420
REFERENCES & RESOURCES
- CMS Medicare Physician Fee Schedule (MPFS) 2025
- Medicare NCCI Coding Policy Manual 2026 - Chapter 7
- CPT® Professional Edition 2025 - American Medical Association
- ICD-10-CM Official Guidelines for Coding and Reporting
- Boston Scientific Cystoscopy-Based Coding and Payment Guide 2026
- American Urological Association (AUA) Clinical Guidelines
Document Status: Complete & Ready for Obsidian Vault
Last Review: February 2026
Next Update Due: December 2026 (2027 Fee Schedule Release)
Crystal's MCW Coder Hub